Continuous Subcutaneous Insulin Infusion versus Multiple daily Insulin Injections in Patients with Type 1 Diabetes Mellitus who Fast during Ramadan: A Systematic Review and Meta-analysis

The benefits and risks of continuous subcutaneous insulin infusion (CSII) or multiple daily injections (MDI) in patients with Type 1 diabetes mellitus (T1DM) who fast during Ramadan are not known.

Source: Diabetes Research and Clinical Practice - February 27, 2019 Category: Endocrinology Authors: Hoda Gad, Hamad Al-Muhannadi, Paul Mussleman, Rayaz A. Malik Tags: Review Source Type: research